UiPath delivered a beat-and-raise quarter and was promoted into a midcap index. Shares of automation software company UiPath ...

UiPath Inc. today announced a preview of its upcoming Agent Builder tool as it outlined its vision to combine its expertise in robotic process automation with generative artificial intelligence models ...

UiPath (PATH) has been resilient in the face of potential disruption from generative AI. At this point, it is fairly clear that the company isn’t a gen AI winner, but the business is looking rather ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...

Business automation software company UiPath Inc. delivered third-quarter earnings and revenue that beat analysts’ expectations, but its stock was heading south in the extended trading session after it ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Figma went public at $33 last July and currently trades at approximately $37. UiPath went public at $56 in April 2021, but it ...

C3.ai, Inc. AI and UiPath Inc. PATH are both high-profile players in the booming AI automation sector. C3.ai specializes in enterprise AI applications, including predictive maintenance and generative ...

UiPath is moving beyond simple, rule-based bots toward "agentic automation." Partnerships are helping to drive scalability of this evolving business. UiPath’s focus on security and transparency could ...